Cyclacel Pharmaceuticals Inc (CYCC)

Currency in USD
9.4000
+0.3500(+3.87%)
Real-time Data·
CYCC Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CYCC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
8.95009.4500
52 wk Range
3.0801597.6000
Key Statistics
Prev. Close
9.05
Open
9.01
Day's Range
8.95-9.45
52 wk Range
3.0801-597.6
Volume
66.63K
Average Volume (3m)
1.85M
1-Year Change
-97.34%
Book Value / Share
3.54
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CYCC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Cyclacel Pharmaceuticals Inc Company Profile

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.

Compare CYCC to Peers and Sector

Metrics to compare
CYCC
Peers
Sector
Relationship
P/E Ratio
−1.7x−2.6x−0.5x
PEG Ratio
-−0.020.00
Price/Book
4.7x0.8x2.6x
Price / LTM Sales
1,032.4x8.1x3.3x
Upside (Analyst Target)
-275.5%42.9%
Fair Value Upside
Unlock15.6%6.2%Unlock

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.01 / -0.29
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CYCC Income Statement

People Also Watch

65.38
BMNR
+10.85%
13.2500
INKT
+8.43%
18.22
SRPT
+1.56%
1.665
VOR
-16.33%

FAQ

What Stock Exchange Does Cyclacel Trade On?

Cyclacel is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Cyclacel?

The stock symbol for Cyclacel is "CYCC."

What Is the Cyclacel Market Cap?

As of today, Cyclacel market cap is 14.89M.

What Is Cyclacel's Earnings Per Share (TTM)?

The Cyclacel EPS (TTM) is -9.66.

From a Technical Analysis Perspective, Is CYCC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Cyclacel Stock Split?

Cyclacel has split 7 times.

How Many Employees Does Cyclacel Have?

Cyclacel has 12 employees.

What is the current trading status of Cyclacel (CYCC)?

As of 12 Aug 2025, Cyclacel (CYCC) is trading at a price of 9.40, with a previous close of 9.05. The stock has fluctuated within a day range of 8.95 to 9.45, while its 52-week range spans from 3.08 to 597.60.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.